BR0214264A - Composição, processo de preparação da composição e seus usos - Google Patents

Composição, processo de preparação da composição e seus usos

Info

Publication number
BR0214264A
BR0214264A BR0214264-3A BR0214264A BR0214264A BR 0214264 A BR0214264 A BR 0214264A BR 0214264 A BR0214264 A BR 0214264A BR 0214264 A BR0214264 A BR 0214264A
Authority
BR
Brazil
Prior art keywords
composition
preparing
dermatology
retinoid
cosmetics
Prior art date
Application number
BR0214264-3A
Other languages
English (en)
Other versions
BRPI0214264B1 (pt
BRPI0214264B8 (pt
Inventor
Sandrin E Orsoni
Nathalie Willcox
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8870899&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0214264(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of BR0214264A publication Critical patent/BR0214264A/pt
Publication of BRPI0214264B1 publication Critical patent/BRPI0214264B1/pt
Publication of BRPI0214264B8 publication Critical patent/BRPI0214264B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçãO, PROCESSOS DE PREPARAçãO DA COMPOSIçãO E SEUS USOS". A presente invenção trata de uma composição que compreende, em um meio fisiologicamente aceitável, pelo menos um retinóide, peróxido de benzoíla dispersado e pelo menos um gelificante pH-independente, de seu processo de preparação e de seu uso em cosmética e em dermatologia.
BRPI0214264A 2001-12-21 2002-12-09 composição, processos para sua preparação e usos de uma composição BRPI0214264B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0116747A FR2833841B1 (fr) 2001-12-21 2001-12-21 Gel comprenant au moins un retinoide et du peroxyde de benzoyle
PCT/FR2002/004233 WO2003055472A1 (fr) 2001-12-21 2002-12-09 Gel comprenant au moins un retinoide et du peroxyde de benzoyle

Publications (3)

Publication Number Publication Date
BR0214264A true BR0214264A (pt) 2004-09-21
BRPI0214264B1 BRPI0214264B1 (pt) 2017-04-18
BRPI0214264B8 BRPI0214264B8 (pt) 2021-05-25

Family

ID=8870899

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0214264A BRPI0214264B8 (pt) 2001-12-21 2002-12-09 composição, processos para sua preparação e usos de uma composição

Country Status (22)

Country Link
EP (1) EP1458369B1 (pt)
JP (2) JP4889922B2 (pt)
KR (1) KR101014586B1 (pt)
CN (1) CN1329025C (pt)
AR (1) AR038026A1 (pt)
AT (1) ATE347354T1 (pt)
AU (2) AU2002364437B2 (pt)
BR (1) BRPI0214264B8 (pt)
CA (1) CA2466321C (pt)
CY (1) CY1107583T1 (pt)
DE (2) DE122008000041I1 (pt)
DK (1) DK1458369T3 (pt)
ES (1) ES2275948T3 (pt)
FR (2) FR2833841B1 (pt)
HU (1) HU230439B1 (pt)
MX (1) MXPA04005918A (pt)
PL (1) PL220838B1 (pt)
PT (1) PT1458369E (pt)
RU (1) RU2320327C2 (pt)
SI (1) SI1458369T1 (pt)
WO (1) WO2003055472A1 (pt)
ZA (1) ZA200403759B (pt)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820186B2 (en) 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
EP1813312A3 (en) * 2002-09-05 2010-03-24 Galderma Research & Development Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent
US7544674B2 (en) 2002-10-25 2009-06-09 Galderma S.A. Topical skin care composition
JP2008519764A (ja) * 2004-11-09 2008-06-12 イマジナティブ リサーチ アソシエィツ インコーポレーテッド レチノイド溶液及びそれからつくった調合物
EP2431089A1 (en) 2005-08-02 2012-03-21 Sol-Gel Technologies Ltd. Metal oxide coating of water insoluble ingredients
FR2889662B1 (fr) * 2005-08-11 2011-01-14 Galderma Res & Dev Emulsion de type huile-dans-eau pour application topique en dermatologie
EP1926484A2 (en) * 2005-09-02 2008-06-04 Galderma Research & Development Depigmenting composition for the skin, comprising adapalene, at least one depigmenting agent and at least one anti-inflammatory agent
FR2890314B1 (fr) * 2005-09-02 2009-03-20 Galderma Res & Dev Compositiondepigmentante de la peau comprenant de l'adapalene au moins un agent depigmentant et au moins un agent anti-inflammatoire
US8158109B2 (en) 2006-03-31 2012-04-17 Stiefel Research Australia Pty Ltd Foamable suspension gel
FR2901139B1 (fr) * 2006-05-17 2009-03-20 Galderma Res & Dev S N C Snc Compositions comprenant au moins un derive de l'acide naphtoique et du peroxyde de benzoyle, leurs procedes de preparation, et leurs utilisations
FR2903603B1 (fr) * 2006-07-13 2009-03-20 Galderma Res & Dev S N C Snc Combinaison d'adapalene et de peroxyde de benzole dans le traitement de l'acne
CA2656451C (en) * 2006-07-13 2015-01-27 Galderma Research & Development Composition comprising a retinoid and benzoyl peroxide
FR2903604B1 (fr) * 2006-07-13 2008-09-05 Galderma Res & Dev S N C Snc Composition comprenant un retinoide et du peroxyde de benzoyle
US8080537B2 (en) 2006-07-13 2011-12-20 Galderma Research & Development Combinations of adapalene and benzoyl peroxide for treating acne lesions
FR2909000B1 (fr) * 2006-11-28 2009-02-06 Galderma Res & Dev S N C Snc Compositions comprenant du peroxyde de benzoyle, au moins un derive de l'acide naphtoique et au moins un compose de type polymeres de polyurethane ou des derives de celui-ci, et leurs utilisations.
FR2910321B1 (fr) * 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
FR2910320B1 (fr) * 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
ES2546029T3 (es) * 2007-01-30 2015-09-17 Galderma Research & Development Uso de adapaleno y peróxido de benzoilo para el tratamiento a largo plazo del acné vulgar
KR20090125243A (ko) * 2007-02-01 2009-12-04 솔-겔 테크놀로지스 리미티드 퍼옥사이드 및 레티노이드를 함유하는 국소 도포용 조성물
EP1967180A1 (de) * 2007-03-06 2008-09-10 Almirall Hermal GmbH Topische Zusammensetzung enthaltend einen Retinoid-Rezeptor-Agonist
FR2916966B1 (fr) * 2007-06-11 2011-01-14 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
FR2916975B1 (fr) * 2007-06-11 2009-09-04 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
EP2065032A1 (en) * 2007-11-27 2009-06-03 Galderma Research & Development A method for producing adapalene gels
BRPI0819047A2 (pt) * 2007-11-30 2015-05-05 Galderma Res & Dev "composição, seu processo de preparação e seus usos"
CN102056481A (zh) 2008-06-05 2011-05-11 陶氏制药科学公司 包含低浓度的在水和水混溶性有机溶剂中的悬浮液形式的过氧苯甲酰的局部药物制剂
ES2632717T3 (es) 2008-11-07 2017-09-15 Klox Technologies, Inc. Combinación de un oxidante y un fotoactivador para la cicatrización de heridas
MX2012004211A (es) * 2009-10-07 2012-10-03 Tagra Biotechnologies Ltd Microcapsulas que comprenden peroxido de benzoilo y composiciones topicas que las comprenden.
EP2490528A4 (en) * 2009-10-21 2013-06-12 Dow Pharmaceutical Sciences METHOD FOR ANCHORING A POWDER CONTAINING BENZOYL PEROXIDE
KR20120118064A (ko) 2010-02-09 2012-10-25 갈데르마 리써어치 앤드 디벨로프먼트 염증후 과다색소침착의 감소로 비코카서스인 모집단에서의 여드름 치료를 위한 아다팔렌과 벤조일 퍼옥사이드의 조합물을 포함하는 피부용 조성물
FR2969492B1 (fr) * 2010-12-23 2013-07-05 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant de l'adapalene
FR2969491B1 (fr) * 2010-12-23 2013-07-12 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant une combinaison d'adapalene et de bpo
US8563535B2 (en) 2011-03-29 2013-10-22 Kamal Mehta Combination composition comprising benzoyl peroxide and adapalene
WO2013175011A1 (en) 2012-05-25 2013-11-28 Galderma Research & Development Treatment of preadolescent moderate acne vulgaris
SI2919747T1 (sl) * 2012-11-13 2019-02-28 Galderma S.A. BPO sestava pralnega gela
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
WO2015091828A1 (en) 2013-12-19 2015-06-25 Galderma Research & Development Therapy regimen for treating severe acne related diseases
AU2015239688B2 (en) 2014-04-01 2020-06-25 Galderma Research & Development Combination of adapalene and benzoyl peroxide for treating acne scars
HUE051351T2 (hu) 2014-07-25 2021-03-01 Galderma Res & Dev Adapalén és benzoil-peroxid kombinációja súlyos akne kezelésére
MX2018002176A (es) * 2015-08-20 2018-06-15 Sol Gel Tech Ltd Composiciones para aplicaciones topicas que comprenden peroxido de benzoilo y adapaleno.
WO2018080284A1 (ko) * 2016-10-31 2018-05-03 (주)동구바이오제약 여드름 치료용 약물의 생체이용률을 증진시키는 약학적 조성물
CN106729722B (zh) * 2016-11-21 2020-05-12 成都山信药业有限公司 一种制备稳定复方制剂的方法及复方制剂
SG11202111028YA (en) * 2019-04-04 2021-11-29 Galderma Hoding Sa Isopropylcarbonate benzoyl peroxide compositions and methods of use
JPWO2023112664A1 (pt) * 2021-12-14 2023-06-22

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2378523A1 (fr) * 1977-01-26 1978-08-25 Grupper Charles Medicament pour le traitement de l'acne
US4189501A (en) * 1977-10-07 1980-02-19 A. H. C. Pharmacal, Inc. Composition and method for the treatment of acne
LU85849A1 (fr) * 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
FR2628319B1 (fr) * 1988-03-09 1990-12-07 Oreal Compositions pharmaceutiques et cosmetiques a base de peroxyde de benzoyle et de sels d'ammonium quaternaires
MA22677A1 (fr) * 1991-10-16 1993-07-01 Richardson Vicks Inc Compositions cosmetiques en gels
US5470884A (en) * 1994-05-19 1995-11-28 Procter & Gamble Anti-acne compositions
FR2787322B1 (fr) * 1998-12-18 2002-10-18 Galderma Res & Dev Emulsion huile-dans-eau comprenant un agent actif micronise et un systeme emulsionnant approprie
ATE365543T1 (de) * 1999-12-20 2007-07-15 Henkel Kgaa Tablettierung verdickender systeme
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle

Also Published As

Publication number Publication date
ZA200403759B (en) 2005-11-30
CN1607946A (zh) 2005-04-20
CY1107583T1 (el) 2013-03-13
DE122008000041I1 (de) 2008-11-20
JP4889922B2 (ja) 2012-03-07
DE60216634D1 (de) 2007-01-18
PL220838B1 (pl) 2016-01-29
ATE347354T1 (de) 2006-12-15
HUP0500006A2 (en) 2006-08-28
AU2002364437B2 (en) 2008-08-21
HU230439B1 (hu) 2016-06-28
FR2833841B1 (fr) 2005-07-22
AU2008246274B2 (en) 2011-05-19
AU2002364437A1 (en) 2003-07-15
PL372270A1 (en) 2005-07-11
SI1458369T1 (sl) 2007-04-30
EP1458369A1 (fr) 2004-09-22
CA2466321C (fr) 2011-11-08
DE60216634T2 (de) 2007-09-27
ES2275948T3 (es) 2007-06-16
FR08C0024I2 (pt) 2009-11-20
JP2005513146A (ja) 2005-05-12
PT1458369E (pt) 2007-03-30
HUP0500006A3 (en) 2009-09-28
CN1329025C (zh) 2007-08-01
BRPI0214264B1 (pt) 2017-04-18
AR038026A1 (es) 2004-12-22
FR08C0024I1 (pt) 2008-07-18
CA2466321A1 (fr) 2003-07-10
DK1458369T3 (da) 2007-04-10
WO2003055472A1 (fr) 2003-07-10
KR20050016290A (ko) 2005-02-21
RU2320327C2 (ru) 2008-03-27
AU2008246274A1 (en) 2008-12-11
BRPI0214264B8 (pt) 2021-05-25
JP5478468B2 (ja) 2014-04-23
RU2004122429A (ru) 2005-03-20
KR101014586B1 (ko) 2011-02-16
EP1458369B1 (fr) 2006-12-06
FR2833841A1 (fr) 2003-06-27
MXPA04005918A (es) 2004-11-01
JP2011037904A (ja) 2011-02-24

Similar Documents

Publication Publication Date Title
BR0214264A (pt) Composição, processo de preparação da composição e seus usos
FI941769A0 (fi) Matalan pH:n vesipohjainen kosmeettinen geeli joka sisältää ionittomia polyakryyliamidijohdannaisia
BR0204935A (pt) Composição de tintura para fibras queratìnicas humanas que compreende um colorante direto ou de oxidação e um silicone aminado particular, processo e dispositivos com 2 e 3 compartimentos ou 'kit' para a tintura das fibras queratìnicas humanas
ATE190834T1 (de) Orale zusammensetzung gegen zahnbelag
BR0204979A (pt) Composição cosmética destinada ao tratamento das fibras queratìnicas humanas que compreende um silicone aminado particular, processo de tintura de oxidação, de tratamento e descoloração das fibras queratìnicas humanas, e uso de pelo menos um silicone aminado
BR0205597A (pt) Composição para a tintura de oxidação das fibras queratìnicas, composição pronta para o uso para a tintura de oxidação das fibras queratìnicas, processos de tintura das fibras queratìnicas e dispositivos com vários compartimentos ou 'kit' para a tintura das fibras queratìnicas
KR930703022A (ko) 피부암의 가시화를 위한 생물학적 염색조성물,이것의 제조방법 및 사용방법
ES2153884T3 (es) Composicion cosmetica o dermatologica en forma de aceite gelificado que contiene una mezcla de acido hidroxi-12 estearico o dialquilamida del acido n-lauroilglutamico y de un copolimero estireno/alcadieno hidrogenado.
AR031453A1 (es) COMPOSICION DESTINADA A LA TINTURA DE OXIDACION DE FIBRAS QUERATíNICAS QUE COMPRENDE GLICERINA Y UN POLIOL DIFERENTE DE LA GLICERINA EN UNA RELACION DETERMINADA
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
BR0205620A (pt) Composição para a tintura de oxidação das fibras queratìnicas, composição pronta para o uso para a tintura de oxidação das fibras queratìnicas, processos de tintura das fibras queratìnicas e dispositivos com vários compartimentos ou 'kit' para a tintura das fibras queratìnicas
RU94035673A (ru) Гелеобразная композиция для использования в области косметики и дерматологии
BR0205595A (pt) Composição para a tintura de oxidação das fibras queratìnicas, composição pronta para o uso para a tintura de oxidação das fibras queratìnicas, processos de tintura das fibras queratìnicas e dispositivos com vários compartimentos ou 'kit' para a tintura das fibras queratìnicas
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
FI940696A (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
KR970009581B1 (en) Composition for topical use containing depolymerized deoxyribonucleic acids in the skin and body cosmetic treathent
PT727996E (pt) Formulacoes de febbendazol
NZ237513A (en) Retinoic acid esters, preparation and pharmaceutical/cosmetic compositions thereof
BR0114613A (pt) Composição cosmética, utilização de uma composição cosmética, e, processo de tratamento cosmético das matérias queratìnicas
BR0211784A (pt) Método para reduzir o crescimento capilar humano, uso de alfa-difluorometilornitina, e composição cosmética usada para a redução do crescimento capilar humano
ATE227973T1 (de) Kosmetische, dermatologische und pharmazeutische anwendung eines terminalia catappa pflanzenextrakts
WO2002100371A3 (en) Colored sunscreen compositions
BR0204984A (pt) Composição oxidante para o tratamento das fibras queratìnicas que compreende um silicone aminado particular, processo de tintura de oxidação, tratamento e descoloração das fibras queratìnicas, e uso de pelo menos um silicone aminado
ES2136954T3 (es) Utilizacion de al menos un agua termal de vichy como antagonista de sustancia p.
AR016473A1 (es) Preparado efervescente y procedimiento para su preparacion

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: GALDERMA RESEARCH AND DEVELOPMENT S.N.C. (FR)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 018070033204/SP DE 25/05/2007.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15V Prolongation of time limit allowed

Free format text: RECONHECIDO O OBSTACULO ADMINISTRATIVO E CONCEDIDO A DEVOLUCAO DE PRAZO DE 54 DIAS , NOS TERMOS DO ARTIGO 221 2O DA LPI E DA RESOLUCAO 116/2004.

B25D Requested change of name of applicant approved

Owner name: GALDERMA RESEARCH AND DEVELOPMENT (FR)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 31/07 , A61K 31/19 , A61K 31/20 , A61P 17/00 , A61K 7/48 , A61K 7/06

Ipc: A61K 31/07 (2006.01), A61K 31/19 (2006.01), A61K 3

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B17A Notification of administrative nullity (patentee has 60 days time to reply to this notification)

Free format text: REQUERENTE DA NULIDADE: ASSOCIACAO DOS LABORATORIOS FARMACEUTICOS NACIONAIS. PETICAO NO870170078669 DE 16/10/2017.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/12/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 09/12/2022